IQVIA Holdings Inc. has announced a strategic partnership with NVIDIA to develop custom foundation models and agentic AI workflows aimed at accelerating research, clinical development, and access to new treatments in the life sciences sector. This collaboration will leverage IQVIA's vast healthcare-specific data alongside NVIDIA's advanced technology to enhance and streamline clinical trials and commercial launches through powerful workflow coordination and insights. The new AI agents, unveiled at GTC Paris, are designed to transform business processes and improve patient outcomes by using NVIDIA's NIM Agent Blueprints, NeMo Customizer, and NeMo Guardrails for rapid development and secure deployment. This partnership highlights a pivotal opportunity for both companies to push the frontier of AI in healthcare, promising smarter solutions for the industry.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.